11,11-Dimethyl-5,11-dihydroindeno[1,2-b]carbazole | CAS:1260228-95-2

We serve 11,11-Dimethyl-5,11-dihydroindeno[1,2-b]carbazole CAS:1260228-95-2 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
11,11-Dimethyl-5,11-dihydroindeno[1,2-b]carbazole

Chemical Name:11,11-Dimethyl-5,11-dihydroindeno[1,2-b]carbazole
CAS.NO:1260228-95-2
Synonyms:11,11-dimethyl-5,11-dihydroindeno[1,2-b]carbazole
5,11-dihydro-11,11-dimethylindene[1,2-b]carbazole
Molecular Formula:C21H17N
Molecular Weight:283.36600
 
Specification:
Appearance:White to off-white crystalline powder
Assay:≥98.0%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:OLED intermediates



Contact us for information like 11,11-Dimethyl-5,11-dihydroindeno[1,2-b]carbazole chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,5,11-dihydro-11,11-dimethylindene[1,2-b]carbazole physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,11,11-dimethyl-5,11-dihydroindeno[1,2-b]carbazole Use and application,11,11-Dimethyl-5,11-dihydroindeno[1,2-b]carbazole technical grade,usp/ep/jp grade.


Related News: Retrogenix’s extensive library of human proteins make it uniquely placed for assessing candidate antibodies for target binding.10-Bromo-1-decanol acetate manufacturer Retrogenix’s extensive library of human proteins make it uniquely placed for assessing candidate antibodies for target binding.2-(4-Fluorophenyl)thiophene supplier Large pharmaceutical companies are investing a disproportionately large amount of annual revenue in research and development (R&D), according to GlobalData’s Company Financials database.2-(2-(2,2,2-Trifluoroethoxy)phenoxy)ethyl methanesulfonate vendor Large pharmaceutical companies are investing a disproportionately large amount of annual revenue in research and development (R&D), according to GlobalData’s Company Financials database.Because API companies usually adopt a different synthetic route from the original research company, compared with the drug itself, the impurities contained in the generic drug API have not been verified by the original drug for many years of use and require more careful testing and control.